Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
NCT07514819
Bone Diseases, Bone Neoplasms
Memphis, Tennessee, United States
View Trial DetailsNCT Number: NCT05535283
Clinical study participation has historically been heavily biased toward specific demographics.
Several people will be invited to enroll in this study so that it may collect a variety of data about osteosarcoma clinical trial experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal.
People with osteosarcoma who are invited to take part in medical research will benefit from the analysis of the data.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 months
Time frame: 12 months
Contact information is provided by the study sponsor or research team.
Power Life Sciences Inc.
Industry
An Observational Study Investigating The Experiences of Patients In Osteosarcoma Clinical Trials
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07514819
Bone Diseases, Bone Neoplasms
Memphis, Tennessee, United States
View Trial DetailsNCT07516353
ALL, AML
Boston, Massachusetts, United States
View Trial DetailsNCT07142863
Envafolimab, Neoadjuvant Chemotherapy
Shanghai, China
View Trial DetailsNCT06776198
Neoplasms, Neoplasms by Histologic Type
View Trial Details